Minimal Access Surgery Compared with Medical Management for Gastro-oesophageal Reflux Disease: Five Year Follow-up of a Randomised Controlled Trial (REFLUX)
Overview
Affiliations
Objectives: To determine the long term clinical effectiveness of laparoscopic fundoplication as an alternative to drug treatment for chronic gastro-oesophageal reflux disease (GORD).
Design: Five year follow-up of multicentre, pragmatic randomised trial (with parallel non-randomised preference groups).
Setting: Initial recruitment in 21 UK hospitals.
Participants: Responders to annual questionnaires among 810 original participants. At entry, all had had GORD for >12 months.
Intervention: The surgeon chose the type of fundoplication. Medical therapy was reviewed and optimised by a specialist. Subsequent management was at the discretion of the clinician responsible for care, usually in primary care.
Main Outcome Measures: Primary outcome measure was self reported quality of life score on disease-specific REFLUX questionnaire. Other measures were health status (with SF-36 and EuroQol EQ-5D questionnaires), use of antireflux medication, and complications.
Results: By five years, 63% (112/178) of patients randomised to surgery and 13% (24/179) of those randomised to medical management had received a fundoplication (plus 85% (222/261) and 3% (6/192) of those who expressed a preference for surgery and for medical management). Among responders at 5 years, 44% (56/127) of those randomised to surgery were taking antireflux medication versus 82% (98/119) of those randomised to medical management. Differences in the REFLUX score significantly favoured the randomised surgery group (mean difference 8.5 (95% CI 3.9 to 13.1), P<0.001, at five years). SF-36 and EQ-5D scores also favoured surgery, but were not statistically significant at five years. After fundoplication, 3% (12/364) had surgical treatment for a complication and 4% (16) had subsequent reflux-related operations-most often revision of the wrap. Long term rates of dysphagia, flatulence, and inability to vomit were similar in the two randomised groups.
Conclusions: After five years, laparoscopic fundoplication continued to provide better relief of GORD symptoms than medical management. Adverse effects of surgery were uncommon and generally observed soon after surgery. A small proportion had re-operations. There was no evidence of long term adverse symptoms caused by surgery.
Trial Registration: Current Controlled Trials ISRCTN15517081.
Liu Y, Huang J, Zhong S, Zheng Z, Xu Z, Zhou D Int J Surg. 2024; 111(1):1348-1356.
PMID: 39206849 PMC: 11745681. DOI: 10.1097/JS9.0000000000001998.
Lata T, Trautman J, Townend P, Wilson R Gastroenterol Rep (Oxf). 2023; 11:goad008.
PMID: 37082451 PMC: 10112961. DOI: 10.1093/gastro/goad008.
Puri A, Steven S, Markar S, Boyle N Dis Esophagus. 2023; 36(10).
PMID: 36942526 PMC: 10789235. DOI: 10.1093/dote/doad014.
Wilson R J Gastrointest Surg. 2022; 27(2):466-468.
PMID: 36581763 DOI: 10.1007/s11605-022-05562-z.
Morbidity of antireflux surgery in lung transplant and matched nontransplant cohorts is comparable.
Razia D, Mittal S, Walia R, Tokman S, Huang J, Smith M Surg Endosc. 2022; 37(2):1114-1122.
PMID: 36131161 PMC: 9491650. DOI: 10.1007/s00464-022-09598-9.